Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

BackgroundInflammatory bowel disease (IBD) is a chronic relapsing-remitting disease. An adverse immune reaction toward the intestinal microbiota is involved in the pathophysiology and microbial perturbations are associated with IBD in general and with flares specifically. Although medical drugs are...

Descripción completa

Detalles Bibliográficos

Autores principales:	Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers, John Penders
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2023-02-01
Colección:	Frontiers in Microbiology
Materias:	inflammatory bowel disease Crohn’s disease ulcerative colitis microbiome pharmacomicrobiomics drug treatment
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1107976/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!